3 Brand-Name Food and Beverage Companies That Want In on the Marijuana Craze
Edibles and infused beverages have these well-known snack and beverage businesses seeing green.
Better Buy: Aphria vs. Aurora Cannabis
One of these marijuana stocks has been the bigger winner recently. But which is better poised to win in the future?
Canna Cabana Granted Membership into Canadian Franchise Association
CALGARY , May 17, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (HITI.CN) (HITIF) (2LY.F), an Alberta -based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale...
ACB, IIPR, ACRGF, HEXO Rise amid Mixed Sector Performance
Markets Rebound but Cannabis Stock Performance Is Mixed(Continued from Prior Part)Sector mixedThe cannabis sector is largely mixed today. Whereas Canopy Growth (WEED), CannTrust, Aphria, and a few others have...
New Regime Will Impact Aphria Stock
No one who follows Aphria (NYSE:APHA stock should have been surprised that the company's president, Jakob Ripshtein, resigned on May 14. Ever since interim CEO Irwin Simon was appointed Independent...
Cannabis Stock News Daily Roundup May 15
GrowGeneration (OTCQX: GRWG) has purchased the assets of GreenLife Garden Supply, including two locations in Maine and one in New Hampshire. The acquisition brings the company's total retail and warehouse...
High Tide Successfully Obtains DTC Eligibility for its Common Shares
CALGARY , May 15, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (HITI.CN) (HITIF) (2LY.F), an Alberta -based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale...
Aphria's President To Resign Amid Another Management Reshuffle
Aphria Inc (NYSE: APHA ) on Tuesday announced some management changes. What Happened Aphria announced its President Jakob Ripshtein will resign from the company June 7. Ripshtein was promoted to the role...
Aphria president to depart June 7
Aphria (NYSE: APHA ) President Jakob Ripshtein will resign effective June 7. His duties will be shared among the existing senior management team. More news on: Aphria Inc., Healthcare stocks news,...
Aphria Inc. announces executive appointments and transition
LEADING CONSUMER PACKAGED GOODS EXECUTIVE TO LEAD APHRIA AS CHIEF OPERATING OFFICER ELEVATES TENURED INFORMATION AND SECURITY LEADER ADDS HUMAN RESOURCES VETERAN LEAMINGTON, ON , May 14, 2019...
Aphria has developed integrated greenhouse growing solutions specifically focused on quality production of cannabis. With the authorization of quantity scale marijuana growing, Aphria greenhouse operations are a natural fit.
Grown in greenhouses, Aphria offers premium medical grade cannabis. Located in Leamington, Ontario, in Southwestern Ontario, the heart of the greenhouse-producing sector for plant and produce, Aphria is built from a lengthy background of greenhouse growing and business experience.
The purpose of Aphria’s Facebook page is to engage with patients, clients, health care professionals and the community through sharing and discussing Aphria products and services, industry insiders and government updates. Please review our community guidelines designed to help provide an inclusive environment for all of Aphria’s communities.
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.
Aphria Inc.’s ISS Governance QualityScore as of January 28, 2019 is 10. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 6; Compensation: 9.
For PatientsAt Aphria, we understand that every patient’s situation is unique, which is why we provide a personalized level of care to suit the individual needs of each patient. Our patient care does not stop with the initial consultation. Our team is committed to providing guidance and continued support throughout the entire patient experience. For Health ProfessionalsGovernment and regulatory bodies set the baseline standards for medicines like medical cannabis. These standards are generally the minimum requirements necessary to ensure an adequate product. Aphria believes adequate is not good enough. Consistency, safety, andefficacy are our priority.
For InvestorsWe are committed to providing pharma-grade medical cannabis and superior patient care, while balancing patient economics and returns to shareholders.